Wang-Da Liu
Overview
Explore the profile of Wang-Da Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
295
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Tang C, Chang J, Ho S, Liu W, Pan M, Chang S, et al.
Life Sci
. 2024 Oct;
357:123114.
PMID: 39369845
Background: A significant number of coronavirus disease 2019 (COVID-19) survivors are experiencing long COVID, with symptoms lasting beyond three months. While diverse long COVID symptoms are established, there are gaps...
12.
Chen K, Liu W, Weng K, Chen H, Ho S, Huang Y, et al.
J Microbiol Immunol Infect
. 2024 Sep;
57(6):961-965.
PMID: 39227237
Monkeypox (Mpox) has emerged as a global threat since 2022. We reported 14 cases of Mpox in 10 people with HIV (PWH) and 4 people without HIV (PWoH), of whom...
13.
Lin K, Sun H, Liu W, Lin C, Tsai M, Chuang Y, et al.
J Microbiol Immunol Infect
. 2024 May;
57(5):739-748.
PMID: 38816319
Background: Male hypogonadism is not uncommon in people with HIV (PWH), with estimated prevalence ranging from 9% to 16%. Existing data are limited on the serum testosterone levels in PWH...
14.
Tsai M, Sun H, Su L, Lin K, Liu W, Huang Y, et al.
J Microbiol Immunol Infect
. 2024 May;
57(4):629-637.
PMID: 38777653
Background: Mycoplasma genitalium is an emerging etiology of sexually transmitted infections (STIs) with increasing resistance to antimicrobials. Surveillance on the epidemiology of M. genitalium infection and antimicrobial resistance is warranted....
15.
Liu W, Feng P, Cheng C, Chou C, Lee C, Lu M, et al.
Infect Dis Ther
. 2024 May;
13(7):1575-1588.
PMID: 38771550
Introduction: Ropeginterferon alfa-2b is a novel mono-pegylated proline-interferon. This clinical study aimed to evaluate its antiviral efficacy of ropeginterferon alfa-2b against SARS-CoV-2 infection. Methods: This is a multicenter, randomized, open-label...
16.
Ma W, Liu W, Sun H, Sheng W, Hsieh S, Wu S, et al.
J Microbiol Immunol Infect
. 2024 Apr;
57(3):426-436.
PMID: 38632022
Background: The prognosis for people living with HIV (PLWH) who develop lymphomas has been greatly improved by combination antiretroviral therapy (cART) and anti-CD20 monoclonal antibodies. However, real-world clinical data on...
17.
Wu T, Lin K, Su L, Sun H, Huang Y, Liu W, et al.
Front Med (Lausanne)
. 2024 Apr;
11:1328589.
PMID: 38560383
Background: Concurrent sexually transmitted infections (STIs) are common in sexually active populations. We aimed to estimate the prevalence and coinfection rates of bacterial STIs among sexually active, HIV-positive men who...
18.
Wu T, Chen P, Wang J, Liu W, Chen Y, Chang S
J Antimicrob Chemother
. 2024 Mar;
79(5):1196-1200.
PMID: 38538154
No abstract available.
19.
Wu T, Tsai W, Chen K, Huang S, Huang C, Kuo P, et al.
J Microbiol Immunol Infect
. 2024 Mar;
57(3):403-413.
PMID: 38480093
Background: Patients with hematological malignancies (HM) were at a high risk of developing severe disease from coronavirus disease 2019 (COVID-19). We aimed to assess the clinical outcome of COVID-19 in...
20.
Liu W, Lin M, Sun H, Shih M, Chuang Y, Huang Y, et al.
J Microbiol Immunol Infect
. 2024 Mar;
57(4):554-563.
PMID: 38429206
Background: Real-world vaccine effectiveness following the third dose of vaccination against SARS-CoV-2 remains less investigated among people with HIV (PWH). Methods: PWH receiving the third dose of BNT162b2 and mRNA-1273...